CONNECT WITH US
HealthTech

HealthTech

Mass General Brigham Spinout Aevius Raises $22M to Make Medicine Computable

HIT Consultant logo

Published on

Add as a preferred source on Google
Mass General Brigham Spinout Aevius Raises $22M to Make Medicine Computable

Aevius co-founders (from left to right): Long Phi Le, Rowland Pettit, Ming Yang (Max) Lu, and Faisal Mahmood. Photo credit: Aevius

Boston-based clinical intelligence company Aevius —a spinout from Mass General Brigham (MGB) —announced that it has raised $22M in funding led by global software investor Insight Partners to accelerate model development, team expansion, and enterprise commercial deployment.

Aevius was founded by Rowland Pettit, M.D., Ph.D. (CEO), Ming Yang (Max) Lu, Ph.D. (CTO), Faisal Mahmood, Ph.D., and Long Phi Le—key members of the founding team behind Modella AI, which was previously acquired by AstraZeneca.

Renowned physician-scientist and digital medicine authority Eric Topol, M.D., serves as Chair of Aevius’s Scientific Advisory Board, underscoring the platform’s commitment to clinical rigor and accuracy grounded in longitudinal patient histories.

Rather than relying on text-only large language models that reconstruct patient context one question at a time, Aevius trains multimodal AI models across structured EHR fields, unstructured clinical notes, and specialty medical data to generate a refreshable multimodal patient representation.

Rather than piecing together fragmented answers from unstructured progress notes one query at a time, Aevius develops foundational models trained across structured clinical tables, unstructured clinical text, and specialty multimodal medical data such as pathology, imaging, and genomics. By learning longitudinal relationships across a patient’s entire medical history, the platform constructs a refreshable multimodal patient representation—a living, computable mathematical state of the patient’s clinical condition and trajectory that updates dynamically as new encounters, diagnostics, and treatments occur.

Because this unified representation captures the whole patient rather than isolated data fragments, enterprise teams and downstream AI agents can build multiple clinical and operational applications on top of a single reusable foundation.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.